Abstract:
An object of the present invention is to provide a hollow-fiber membrane blood purification device having an improved antioxidant performance, good water permeation performance and blood compatibility performance, and economic rationality. The present invention provides a hollow-fiber membrane blood purification device including hollow-fiber membranes filled in a vessel, in which the hollow-fiber membranes contain a hydrophobic polymer, a hydrophilic polymer and a fat-soluble vitamin, when a hollow-fiber membrane bundle is divided into five sections in a lengthwise direction and divided sections positioned in endmost portions are defined as body end portions, an amount of the fat-soluble vitamin present in at least one of the body end portions is the largest among amounts of the fat-soluble vitamin present respectively in all the divided sections, and an amount of the fat-soluble vitamin per m 2 of a hollow-fiber membrane inner surface of the at least one body end portion is 20 mg/m 2 or more and 300 mg/m 2 or less.
Abstract:
An object of the present invention is to provide a porous hollow-fiber membrane having high strength while maintaining high pure-water permeation performance. A porous hollow-fiber membrane of the present invention is a porous hollow-fiber membrane including a fluororesin-based polymer, in which the porous hollow-fiber membrane has a columnar texture oriented in a longitudinal direction of the porous hollow-fiber membrane, and a molecular chain of the fluororesin-based polymer is oriented in the longitudinal direction of the porous hollow-fiber membrane.
Abstract:
The invention concerns a method for producing a superhydrophobic membrane or surface coating of a substrate from an aqueous phase comprising the following steps: a) Preparing an aqueous dispersion by dispersing particles of hydrophobic polymer(s) in an aqueous solution of protic polymer(s), wherein the protic polymer(s) and the hydrophobic polymer(s) are present in a weight ratio of protic polymer(s) : hydrophobic polymer(s) in a range of 5 : 95 to 22 : 78, b) electrospinning the dispersion of step a) onto a carrier for producing the membrane or onto the surface for producing the surface coating thereby producing at least one fiber and a nonwoven fabric from the fiber, c) subjecting the nonwoven fabric to a sol-gel process, wherein a precursor/precursors of the sol-gel comprise(s) an alkoxysilane, and d) curing the nonwoven fabric obtained by step c) at a temperature in a range of 50°C to 150°C.
Abstract:
A simple method of manufacturing a silica membrane which has high separation performance and high permeation flux is provided. The method is a method for manufacturing a silica membrane 1 by depositing a silica sol on a porous substrate 11, drying the silica sol by air blowing which has a dew point of -70 to 0°C, and then firing the same thereafter to produce the silica membrane 1. Further, the silica sol is preferably dried by air blowing at an air velocity of 5 to 20 m/sec.
Abstract:
An object of the present invention is to provide a hollow-fiber membrane blood purification device having an improved antioxidant performance, good water permeation performance and blood compatibility performance, and economic rationality. The present invention provides a hollow-fiber membrane blood purification device including hollow-fiber membranes filled in a vessel, in which the hollow-fiber membranes contain a hydrophobic polymer, a hydrophilic polymer and a fat-soluble vitamin, when a hollow-fiber membrane bundle is divided into five sections in a lengthwise direction and divided sections positioned in endmost portions are defined as body end portions, an amount of the fat-soluble vitamin present in at least one of the body end portions is the largest among amounts of the fat-soluble vitamin present respectively in all the divided sections, and an amount of the fat-soluble vitamin per m 2 of a hollow-fiber membrane inner surface of the at least one body end portion is 20 mg/m 2 or more and 300 mg/m 2 or less.
Abstract translation:本发明的目的是提供一种中空纤维膜血液净化装置,其具有改进的抗氧化性能,良好的水渗透性能和血液相容性能以及经济合理性。 本发明提供一种中空纤维膜血液净化装置,其包括填充在容器中的中空纤维膜,其中中空纤维膜含有疏水性聚合物,亲水性聚合物和脂溶性维生素,当中空纤维膜 束在长度方向上分为五个部分,并且位于最末端的分割部分被定义为主体端部,存在于至少一个身体端部中的脂溶性维生素的量在脂肪的量中最大 所有分割部分分别存在的可溶性维生素,至少一个身体端部的中空纤维膜内表面的每摩尔脂溶性维生素的量为20mg / m 2以上且300mg以下 / m 2以下。
Abstract:
The invention relates to a method for manufacturing a filtration membrane including the following steps: a) selecting and preparing an organic polymer, such as a collodion; b) injecting a collodion into at least one channel of an extrusion die that also comprises an extrusion die core and at least one outlet; c) injecting an internal liquid into a hollow centering pin, the hollow centering pin comprising a channel positioned on the core of the extrusion die and also positioned at an axis of the outlet of the extrusion die; d) applying a holding film to the outlet of the extrusion die; e) unrolling the holding film onto a surface of at least one hollow fiber emerging from the outlet of the extrusion die; f) immersing the hollow fiber with the first holding film in a rinsing solution so as to obtain a flat hollow fiber filtration membrane; and ending the rinsing of the filtration membrane.
Abstract:
A method for manufacturing a zeolite membrane with fewer defects; a zeolite membrane having oxygen eight-membered rings with fewer defects; and a method for evaluating a zeolite membrane having oxygen eight-membered rings which enables to evaluate defects are provided. The zeolite membrane is manufactured by: subjecting a porous body to heat treatment at 400°C or more in the presence of oxygen as pretreatment, before adhering zeolite seed crystals to a surface of the porous body; storing the porous body under an environment of humidity of 30% or more for 12 hours or more after the heat treatment; and subsequently adhering the zeolite seed crystals to the porous body. The zeolite membrane having oxygen eight-membered rings, which is manufactured by subjecting the porous body to the heat treatment, provides a value that is obtained by dividing a permeance of CF 4 by a permeance of CO 2 to be 0.015 or less, and has fewer defects.